英国批准新的癌症药物Keytruda用于子宫癌,将死亡风险降低26%。 UK approves new cancer drug Keytruda for advanced womb cancer, reducing death risk by 26%.

联合王国卫生官员批准了一种新的治疗方法,即子宫癌(Keytruda),每年为大约2 100名妇女提供希望。 Health officials in the UK have approved a new treatment, pembrolizumab (Keytruda), for advanced womb cancer, offering hope to around 2,100 women annually. 免疫治疗药物与化疗相结合,将死亡风险降低26%,并减缓癌症的蔓延。 The immunotherapy drug, when combined with chemotherapy, reduces the risk of death by 26% and slows cancer progression. 这标志着在治疗晚期子宫颈癌方面取得的重大进步。 This marks a significant advancement in treating advanced endometrial cancer.